TrialDigestive diseases and sciences2008

Treatment of Crohn's disease with leflunomide as second-line immunosuppression : a phase 1 open-label trial on efficacy, tolerability and safety.

Martin H Holtmann et al.PubMed ↗Publisher ↗

No numbers read from the abstract.